Zacks Investment Research on MSN

How to play Eli Lilly stock following a robust Q4 earnings report

Eli Lilly and Company LLY announced robust fourth-quarter results on Feb. 4. Lilly beat estimates for both earnings and sales and issued an upbeat guidance for 2026. Adjusted earnings per share of $7.

10% of CT residents use an expensive weight-loss drug. The state has an unusual idea to cut prices

After Bonnie had part of her thyroid removed, weight gain accompanied the aftermath of the procedure. The Connecticut ...
The Silicon Review

Zepbound vs Wegovy: One Hormone or Two, Here's What Changes

Compare Zepbound and Wegovy to understand how one hormone vs two impacts weight loss, appetite control, side effects, and ...